Thapa R, Paudyal V, Sharma M, Ratnani I, Surani S. Artificial intelligence advancement in addressing cough. World J Clin Cases 2026; 14(7): 118581 [DOI: 10.12998/wjcc.v14.i7.118581]
Corresponding Author of This Article
Salim Surani, MD, FACP, FCCP, Professor, Department of Medicine, University of Houston, 4302 University Drive, Houston, TX 77004, United States. srsurani@hotmail.com
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Mar 6, 2026 (publication date) through Mar 5, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Thapa R, Paudyal V, Sharma M, Ratnani I, Surani S. Artificial intelligence advancement in addressing cough. World J Clin Cases 2026; 14(7): 118581 [DOI: 10.12998/wjcc.v14.i7.118581]
Rubi Thapa, Vivek Paudyal, Department of General Practice and Emergency Medicine, Karnali Academy of Health Sciences, Jumla 21200, Nepal
Munish Sharma, Department of Pulmonary and Critical Care Medicine, Baylor Scott and White, Temple, LA 76508, United States
Iqbal Ratnani, Department of Anesthesiology, Houston Methodist, Houston, TX 77030, United States
Salim Surani, Department of Medicine, University of Houston, Houston, TX 77004, United States
Salim Surani, Department of Medicine, Aga Khan University, Nairobi 30270, Nairobi City, Kenya
Author contributions: Sharma M and Surani S conceptualized the study; Thapa R, Paudyal V, Sharma M, and Surani S carried out the literature review and initial drafting of the manuscript; Thapa R prepared the figures and tables; Sharma M, Ratnani I, and Surani S undertook manuscript revision and editing; all authors have read and approved the final version of the manuscript.
Conflict-of-interest statement: None of the authors have any conflict of interest to disclose.
Corresponding author: Salim Surani, MD, FACP, FCCP, Professor, Department of Medicine, University of Houston, 4302 University Drive, Houston, TX 77004, United States. srsurani@hotmail.com
Received: January 6, 2026 Revised: January 22, 2026 Accepted: February 6, 2026 Published online: March 6, 2026 Processing time: 58 Days and 17.2 Hours
Abstract
Cough assessment is a vital component of clinical management for pulmonary disorders, yet effective tools to execute quantification are insufficient. The dominant approach incorporates acoustic evaluation, primarily based on cough sounds. Incorporating artificial intelligence (AI), particularly machine learning and deep learning, is poised to revolutionize this field. Although AI’s application is focused mainly on curative cough management, there is modest yet growing interest in using this technology for preventive medicine. However, these advancements are accompanied by technical, ethical, and legal challenges that must be resolved to leverage their full potential. Furthermore, to ensure reliability and address concerns of medical practitioners about technological replacement, the human-in-loop model should be advocated. This overview summarizes recent advancements in AI for cough medicine, covering its current clinical applications, existing limitations, strategies to address these challenges, and future opportunities.
Core Tip: Evaluating cough for pulmonary conditions relies substantially on acoustic measurement, yet existing quantification tools remain suboptimal. Integrating artificial intelligence (AI), particularly machine learning and deep learning, offers a promising pathway for both therapeutic and preventive applications in cough medicine. Current implementations remain confined to weak AI’s predefined roles, while advances in artificial general intelligence hold the potential to overcome these adaptability constraints. Moreover, harnessing current potential requires resolving key technical, ethical, and legal issues by integrating explainable AI, multimodal hybrid approaches, and robust accountability measures within human-centered frameworks.